Why cutting drug prices is pushing Eli Lilly’s stock to all-time highs
Up next
Author


Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation.

You May Also Like
ChargePoint stock down more than 20% after revenue warning, CEO change

ChargePoint stock down more than 20% after revenue warning, CEO change

Shares of ChargePoint Holdings Inc. tanked more than 20% in the extended…
As Nvidia’s stock gains, one analyst shows why Stargate could be so significant

As Nvidia’s stock gains, one analyst shows why Stargate could be so significant

Will Nvidia become part of the “Trump trade”? Melius Research says the…
Why Powell and the Fed might pause interest-rate cuts in December

Why Powell and the Fed might pause interest-rate cuts in December

Some say November’s jobs data support holding monetary policy steady.
Can Coinbase really grow bigger than Charles Schwab in 2025? Here’s what could make that bold call a reality.

Can Coinbase really grow bigger than Charles Schwab in 2025? Here’s what could make that bold call a reality.

A weekly look at the most important news and moves in crypto,…